Loading resource…

Institute of Hematology and CREO, University of Perugia, Perugia, Italy
The paper discusses significant advancements in the classification of myeloid neoplasms since the 4th WHO edition, highlighting the introduction of new entities and refined diagnostic criteria. It emphasizes the importance of understanding these classifications for accurate diagnosis and treatment of adult myelodysplastic syndromes and acute myeloid leukemia. The authors aim to clarify the differences and similarities between the two classification systems, providing insights into their clinical implications.
Sign in to open
Answers use this document only.
Your first question is free.
Resources from the same specialty and type. Curated links will replace these when added.
Documents that extend or complement this resource.

Myeloproliferative Neoplasms
Same clinical topic · Hematology

MASTOCYTOSIS
Same clinical topic · Hematology

MYELODYSPLASTIC SYNDROMES: 2023 UPDATE ON DIAGNOSIS, RISK-STRATIFICATION, AND MANAGEMENT
Same clinical topic · Hematology

PERIPHERAL T-CELL LYMPHOMAS
Same clinical topic · Hematology

VEXAS SYNDROME: A COMPREHENSIVE REVIEW OF PATHOGENESIS, CLINICAL SPECTRUM, AND THERAPEUTIC STRATEGIES
Same clinical topic · Hematology

IRON DEFICIENCY
Same clinical topic · Hematology

MULTIPLE MYELOMA: 2026 UPDATE ON DIAGNOSIS, RISK-STRATIFICATION AND MANAGEMENT
Same clinical topic · Hematology

ANTIDOTES FOR ANTICOAGULATION REVERSAL
Same clinical topic · Hematology

POST-TRANSPLANTATION CYCLOPHOSPHAMIDE AND ANTHYMOCTE GLOBULIN IN 8/10 HLA-MISMATCHED UNRELATED DONOR TRANSPLANTATION
Same clinical topic · Hematology